HEM — Hemostemix Cashflow Statement
0.000.00%
Last trade - 00:00- CA$10.88m
- CA$13.74m
Annual cashflow statement for Hemostemix, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -6.29 | -5.24 | -2.5 | -2.62 | -4.71 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0.247 | 0.351 | 0.527 | 0.946 | 0.529 |
| Unusual Items | |||||
| Purchased R&D | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 2.82 | -1.71 | 0.555 | -0.232 | -0.35 |
| Change in Accounts Receivable | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -3.48 | -6.1 | -1.42 | -1.9 | -4.53 |
| Other Investing Cash Flow Items | 0.171 | 0 | — | — | -0.146 |
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0.171 | 0 | — | — | -0.146 |
| Financing Cash Flow Items | -0.064 | -0.202 | -0.078 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 3.27 | 6.02 | 1.44 | 2.45 | 4.66 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.039 | -0.084 | 0.02 | 0.55 | -0.024 |